Omega-3 fatty acids play an important role in cardiovascular health. Although it is suggested that individuals obtain these nutrients through diet, many prefer to rely on supplements. Fish oil supplements are widely used, yet large capsule sizes and tolerability make them less than ideal. Recently, krill oil has emerged as a potential alternative for omega-3 supplementation. This article will discuss what is known about krill oil and its potential use in cardiovascular risk prevention.
Get full access to this article
View all access options for this article.
References
1.
Kris-EthertonP.M.HarrisW.S.AppelL.J.Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation.2002; 21: 2747–2757.
2.
RauchB.SchieleR.SchneiderS.OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation.2010; 21: 2152–2159.
3.
BoschJ.GersteinH.C.DagenaisG.R.n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med.2012; 4: 309–318.
4.
DiNicolantonioJ.J.NiaziA.K.O'KeefeJ.H.LavieC.J.Explaining the recent fish oil trial “failures.”J Glycomics Lipidomics.2012; 4: 10–13.
KwantesJ.M.GrundmannO.A brief review of krill oil history, research, and the commercial market [published online ahead of print April 1, 2014]. J Dietary Suppl.
TouJ.C.Krill for human consumption: Nutritional value and potential health benefits. Nutr Rev.2007; 2: 63–77.
11.
SchuchardtJ.P.Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations – a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis.2011; 1: 145.
12.
HarrisW.S.The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr.2008; 6: 1997S–2002S.
13.
LeafA.AlbertC.M.JosephsonM.Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation.2005; 18: 2762–2768.
14.
ThiesF.GarryJ.M.YaqoobP.Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial. Lancet.2003; 9356: 477–485.
15.
HarrisW.S.n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr.1997; 5(Suppl): 1645s–54s.
16.
GeleijnseJ.M.GiltayE.J.GrobbeeD.E.DondersA.R.KokF.J.Blood pressure response to fish oil supplementation: Metaregression analysis of randomized trials. J Hypertension.2002; 8: 1493–1499.
17.
MozaffarianD.GeelenA.BrouwerI.A.GeleijnseJ.M.ZockP.L.KatanM.B.Effect of fish oil on heart rate in humans: A meta-analysis of randomized controlled trials. Circulation.2005; 13: 1945–1952.
18.
KnappH.R.Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr.1997; 5(Suppl): 1687S–98S.
19.
ItariuB.K.ZeydaM.HochbruggerE.E.Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: A randomized controlled trial. Am J Clin Nutr.2012; 5: 1137–1149.
20.
MakiK.C.ReevesM.S.FarmerM.Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res.2009; 9: 609–615.
21.
UlvenS.M.KirkhusB.LamglaitA.Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids.2011; 46: 37–46.
22.
LaidlawM.CockerlineC.A.RoweW.J.A randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction. Lipids Health Dis.2014; 13: 99.
23.
BergeK.Musa-VelosoK.HarwoodM.HoemN.BurriL.Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Nutr Res.2014; 2: 126–133.
24.
McKenneyJ.M.SicaD.Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy.2007; 5: 715–728.
25.
YoshidaH.YanaiH.ItoK.Administration of natural astaxanthin increases serum HDL-cholesterol and adipo-nectin in subjects with mild hyperlipidemia. Atherosclerosis.2010; 2: 520–523.
26.
BuneaR.El FarrahK.DeutschL.Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev.2004; 4: 420–428.
27.
StoneN.J.RobinsonJ.LichtensteinA.H.2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation.2014; 129(25 Suppl 2): S1–45.
